Five-year cancer incidence after new cardiovascular disease: a population study

Clicks: 1
ID: 323341
2026
Free PDF
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This article has not been analysed, so there is no overall score — reader engagement is measured and shown alongside.
AI Quality Assessment
Not analyzed
Readership in this journal

Ranked #154 of 282 articles by views in European heart journal supplements : journal of the European Society of Cardiology

Most read Least read

Bar heights use a square-root scale. Only the 120 most-read articles are drawn; the journal has 282 in total.

Mint this article as an NFT
Not yet minted

Create a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.

5 SUSD one-off · no wallet required
Sign in to mint
Abstract
Abstract Background Patients with cardiovascular disease (CVD) have an increased risk of cancer, partly due to shared risk factors, chronic inflammation and systemic mediators. However, most previous studies have focused on individuals with pre-existing CVD. Whether patients with a new diagnosis of CVD are at particularly high risk of incident cancer, and whether the spectrum of cancer types differs from that of the general population, remains insufficiently explored. Purpose To describe the five-year incidence of cancer in patients with a new diagnosis of CVD in our healthcare area and to compare the distribution of cancer types with that reported in the general population. Methods We conducted a population-based cohort study using clinical databases from our healthcare area. All adults (>18 years) without a previous history of cancer who were newly diagnosed with CVD between 2010 and 2022 were included. Incident cancers diagnosed between 3 months and 5 years after the index CVD diagnosis were recorded. The incidence and distribution of cancer types were analysed and compared with data from the general population. Results A total of 9,900 patients with newly diagnosed CVD and no prior cancer history were identified. The mean age of the cohort was 64 years, 43% were women, and comorbidities were frequent. During follow-up, 1,922 patients (19.4%) developed incident cancer within five years. Patients who developed cancer were more often male, older, and had a higher burden of comorbidities than those who did not. Among CVD subtypes, chronic heart failure was associated with the highest risk of incident cancer. The most frequently diagnosed cancers were gastrointestinal (27%), lung (14.5%), genitourinary (13.5%) and male reproductive system cancers (13.4%). Conclusions In our healthcare area, the five-year incidence of cancer following a new diagnosis of CVD was markedly high. Moreover, the distribution of cancer types in this population differed from that of the general population, with a higher proportion of genitourinary cancers and a lower proportion of breast cancer. These findings highlight the importance of cancer awareness and surveillance strategies in patients with newly diagnosed CVD.Table.Basal characteristics. Figure.Types of incident cancer.
Reference Key
openalex_W7172346928 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors P Moliner, H Morillas, A Ricarte-Marin, N Lopez-Fernandez, S Jovells-Vaque, A E Cosa, A Pons-Riverola, A Garay, S Jimenez-Marrero, R Ramos, J Berdejo, C Enjuanes, E Hidalgo-Quiros, M Soler, J Comin-Colet
Journal European heart journal supplements : journal of the European Society of Cardiology
Year 2026
DOI
10.1093/eurheartjsupp/suag097.071
URL
https://doi.org/10.1093/eurheartjsupp/suag097.071
Keywords Keywords not found

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.